Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma

Neoplasia (United States)

Volumn 14, Issue 9, 2012, Pages 807-812

  Nord, Karolin H ^a   Paulsson, Kajsa ^a   Veerla, Srinivas ^b   Wejde, Johan ^c   Brosjö, Otte ^c   Mandahl, Nils ^a   Mertens, Fredrik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 20; CHROMOSOME 22; CHROMOSOME 5; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOGENETICS; DISEASE ASSOCIATION; DISOMY; FEMALE; GENE EXPRESSION PROFILING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPERHAPLOIDY; INFLAMMATORY LEIOMYOSARCOMA; LEIOMYOSARCOMA; MALE; MONOSOMY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84866550537     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.12930     Document Type: Article

References (20)

1. Merchant W, Calonje E, and Fletcher CDM (1995). Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma. Histopathology 27, 525-532.
2. Fletcher CDM, van den Berg E, and Molenaar WM (2002). Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleomorphic sarcoma. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. CDM Fletcher, KK Unni, and F Mertens (Eds). IARC Press, Lyon, France. pp. 120-122.
3. Coindre JM (2002). Inflammatory malignant fibrous histiocytoma/undifferentiated pleomorphic sarcoma with prominent inflammation. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. CDM Fletcher, KK Unni, and F Mertens (Eds). IARC Press, Lyon, France. p. 125.
4. Dal Cin P, Sciot R, Fletcher CDM, Samson I, De Vos R, Mandahl N, Willén H, Larsson O, and Van den Berghe H (1998). Inflammatory leiomyosarcoma may be characterized by specific near-haploid chromosome changes. J Pathol 185, 112-115.
5. Chang A, Schuetze SM, Conrad EU III, Swisshelm KL, Norwood TH, and Rubin BP (2005). So-called "inflammatory leiomyosarcoma": a series of 3 cases providing additional insights into a rare entity. Int J Surg Pathol 13, 185-195.
6. Mandahl N, Johansson B, Mertens F, and Mitelman F (2012). Disease-associated patterns of disomic chromosomes in hyperhaploid neoplasms. Genes Chromosomes Cancer 51, 536-544.
7. Olsson L, Paulsson K, Bovée JVMG, and Nord KH (2011). Clonal evolution through loss of chromosomes and subsequent polyploidization in chondrosarcoma. PLoS One 6, e24977.
8. Shaffer LG, Slovak ML, and Campbell LJ (Eds.) (2009). ISCN (2009): an International System for Human Cytogenetic Nomenclature. S. Karger, Basel.
9. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, and Lee C (2004). Detection of large-scale variation in the human genome. Nat Genet 36, 949-951.
10. Gibault L, Pérot G, Chibon F, Bonnin S, Lagarde P, Terrier P, Coindre JM, and Aurias A (2011). New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics. J Pathol 223, 64-71.
11. Johnson WE, Li C, and Rabinovic A (2007). Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127.
12. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102, 15545-15550.
13. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M, Laurila E, et al. (2003). PGC-1α- responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267-273.
14. Harrison CJ, Moorman AV, Broadfield ZJ, Cheung KL, Harris RL, Reza Jalali G, Robinson HM, Barber KE, Richards SM, Mitchell CD, et al. (2004). Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. Br J Haematol 125, 552-559.
15. Safavi S, Forestier E, Golovleva I, Barbany G, Nord KH, Moorman AV, Harrison CJ, Johansson B, and Paulsson K (2012). Loss of chromosomes is the primary event in near-haploid and low hypodiploid acute lymphoblastic leukemia. Leukemia. DOI: 10.1038/leu.2012.227, E-pub ahead of print.
16. Veitia RA, Bottani S, and Birchler JA (2008). Cellular reactions to gene dosage imbalance: genomic, transcriptomic and proteomic effects. Trends Genet 24, 390-397.
17. Edger PP and Pires JC (2009). Gene and genome duplications: the impact of dosage-sensitivity on the fate of nuclear genes. Chromosome Res 17, 699-717.
18. Reik W and Walter J (2001). Genomic imprinting: parental influence on the genome. Nat Rev Genet 2, 21-32.
19. Luedi PP, Dietrich FS, Weidman JR, Bosko JM, Jirtle RL, and Hartemink AJ (2007). Computational and experimental identification of novel human imprinted genes. Genome Res 17, 1723-1730.
20. Gimelbrant A, Hutchinson JN, Thompson BR, and Chess A (2007). Widespread monoallelic expression on human autosomes. Science 318, 1136-1140